MedTrace Logo

Non-Invasive Imaging of Atherosclerosis

NCT01418313 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 886

Last updated 2020-08-03

No results posted yet for this study

Summary

The purpose of this study is to develop and validate novel magnetic resonance imaging (MRI), dynamic contrast enhanced (DCE)-MRI and positron emission tomography (PET)/MR techniques for the detection and risk stratification of patients with atherosclerosis.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Zahi A Fayad, PhD · Icahn School of Medicine at Mount Sinai

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2020-03-09
Completion
2020-03-09

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01418313 on ClinicalTrials.gov